GlassScriptPhysician profile
Annie Pratt
NPI 1548644206
$7,637.24
in general payments reported to CMS, 2019-2025
25 companies · $3,467 in 2025
The $3,467 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $559 · 2022: $927 · 2023: $829 · 2024: $1,855 · 2025: $3,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,066 · Education: $85.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,065.79 |
| Education | $85.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,028.07 | 2021-2025 | |
| Incyte Corporation | $800.50 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $797.26 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $662.96 | 2021-2025 | Winlevi, Absorica Ld |
| Pfizer INC. | $616.86 | 2021-2025 | |
| Ucb, INC. | $532.37 | 2022-2025 | Bimzelx |
| Lilly USA, LLC | $517.66 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $463.51 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $345.85 | 2021-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $264.01 | 2024-2025 | |
| Galderma Laboratories, L.P. | $242.72 | 2022-2025 | Nemluvio, Aklief |
| Genzyme Corporation | $209.56 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $192.21 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $175.86 | 2022-2024 | Vtama |
| Amgen INC. | $165.20 | 2024-2025 | Otezla, Otezla |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $129.80 | 2025 | Vtama |
| Novo Nordisk INC | $106.94 | 2024 | Wegovy |
| Leo Pharma INC. | $101.18 | 2022-2024 | Adbry |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $52.07 | 2021 | |
| Almirall LLC | $51.36 | 2021-2025 | Klisyri, Seysara |
| Lnhc, INC | $23.44 | 2025 | Zelsuvmi |
| Organogenesis INC. | $20.57 | 2024 | |
| Journey Medical Corporation | $18.86 | 2022 | |
| Kyowa Kirin, INC. | $18.43 | 2024 | Poteligeo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Pratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.